Literature DB >> 6370098

Diabetic neuropathy.

M J Brown, A K Asbury.   

Abstract

Peripheral nerve disorders are important late complications of diabetes mellitus. Polyneuropathy, which may involve varying proportions of sensory, motor, and autonomic fibers, is considered the consequence of metabolic derangements that result from chronic hyperglycemia. Symmetrical proximal motor neuropathy ("diabetic amyotrophy") also may have a metabolic basis. Mononeuropathies in diabetes may have an ischemic or compressive cause. Advances have been made in understanding the biochemical basis for diabetic polyneuropathy. The treatment of symptomatic diabetic neuropathy should be directed toward long-term normalization of blood glucose until more specific therapies become available.

Entities:  

Mesh:

Year:  1984        PMID: 6370098     DOI: 10.1002/ana.410150103

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  61 in total

1.  Patterns of contact phase proteins indicating neuropathy in diabetic patients.

Authors:  P Meier; G A Marbet; W Berger; F Duckert; W Friedli
Journal:  Blut       Date:  1990-10

2.  Hyperalgesia in spontaneous and experimental animal models of diabetic neuropathy.

Authors:  L Wuarin-Bierman; G R Zahnd; F Kaufmann; L Burcklen; J Adler
Journal:  Diabetologia       Date:  1987-08       Impact factor: 10.122

3.  Symptomatic focal mononeuropathies in diabetic patients: increased or not?

Authors:  Elefterios Stamboulis; Demetris Vassilopoulos; Nikolaos Kalfakis
Journal:  J Neurol       Date:  2005-02-23       Impact factor: 4.849

4.  Neurotrophic modulation of myelinated cutaneous innervation and mechanical sensory loss in diabetic mice.

Authors:  J A Christianson; J M Ryals; M S Johnson; R T Dobrowsky; D E Wright
Journal:  Neuroscience       Date:  2006-12-16       Impact factor: 3.590

5.  Subclinical diabetic neuropathy: similarities between electrophysiological results of patients with type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetes mellitus.

Authors:  P H Hendriksen; P L Oey; G H Wieneke; B Bravenboer; J D Banga
Journal:  Diabetologia       Date:  1992-07       Impact factor: 10.122

6.  Subclinical diabetic neuropathy with normal conventional electrophysiological study.

Authors:  Jong Seok Bae; Byoung Joon Kim
Journal:  J Neurol       Date:  2007-02-14       Impact factor: 4.849

7.  Antinociceptive effects of chronic administration of uncompetitive NMDA receptor antagonists in a rat model of diabetic neuropathic pain.

Authors:  Shao-Rui Chen; Gary Samoriski; Hui-Lin Pan
Journal:  Neuropharmacology       Date:  2009-05-05       Impact factor: 5.250

8.  Acute inflammatory demyelinating polyneuropathy in a diabetic patient: predominance of vesicular disruption in myelin sheaths.

Authors:  C Vital; C Brechenmacher; J P Cardinaud; G Manier; A Vital; B Mora
Journal:  Acta Neuropathol       Date:  1985       Impact factor: 17.088

9.  Treatment of diabetic autonomic neuropathy with an aldose reductase inhibitor.

Authors:  T J Faes; G A Yff; O DeWeerdt; P Lanting; J J Heimans; F W Bertelsmann
Journal:  J Neurol       Date:  1993       Impact factor: 4.849

10.  Evaluation of thermal and pain sensitivity in type I diabetic patients.

Authors:  X Navarro; W R Kennedy
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-01       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.